- Antihistamine
- Immunotherapy
- Others
House Dust Mite Allergy Treatment Market size was valued at USD 2.1 billion in 2023 and is projected to grow at 14.5% CAGR over the forecast years to reach USD 5.4 billion by 2030. The House Dust Mite Allergy Treatment Market refers to the segment of the healthcare industry focused on products and therapies designed to manage and treat allergies caused by house dust mites (HDM). House dust mites are tiny organisms found in house dust, and their allergens can trigger allergic reactions in susceptible individuals. These allergies can manifest as respiratory issues like asthma and allergic rhinitis (hay fever). House dust mite allergies are prevalent worldwide, affecting a significant portion of the population, especially in regions with high humidity and where house dust mites thrive. House dust mite allergy causes symptoms such as hay fever, cough, runny nose, and itchy red watery eyes.
The growth of the global market for treating house dust mite allergies is primarily fueled by the growing prevalence of allergic conditions linked to dust mites, increasing demand for immunological products, rising investments from both private and government sectors to develop pharmaceutical manufacturing capabilities, and expanding research and development efforts to create anti-allergy medications. According to a chief medical officer at Medscape Education in 2020, approximately 20 million Americans suffer from house dust mite allergies. Furthermore, a study published in the Journal of Scientific Report in March 2022 identified house dust mites as a prominent cause of airway allergic diseases. However, the rise in hygiene practices reduces the occurrence of house dust mite allergy, which, in turn, is expected to restrict the market growth.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
There are different drug approvals by different drug organizations that are helping boost the market growth. For instance, In February 2018, Stallergenes Greer and Shionogi & Co., Ltd. obtained marketing approval for Actair, an allergy immunotherapy drug designed to treat allergic rhinitis caused by house dust mites in Japan. Stallergenes Greer collaborated with Shionogi & Co., Ltd., and submitted a New Drug Application in January 2017. This approval is expected to provide an effective treatment option for house dust mite-induced allergic rhinitis in Japan and expand the market presence of both pharmaceutical companies. Additionally, Merck & Co., Inc. received approval from the U.S. FDA in 2017 for Odactra, an anti-allergy drug aimed at treating nasal inflammation induced by house dust mites in adults. Odactra is administered orally in sublingual form and represents an innovative treatment option for individuals suffering from house dust mite-induced rhinitis, contributing to the company's business growth.
The global house dust mite allergy treatment market size was valued at USD 2.1 billion in 2023 and is projected to grow at 14.5% CAGR over the forecast years to reach USD 5.4 billion by 2030.
The global house dust mite allergy treatment market is segmented based on treatment, drug type, route of administration, and geography.
The leading players in the market of global microbial lipase are Shionogi & Co., Ltd., Stallergenes Greer, Merck & Co., Inc., Torii Pharmaceutical Co., Ltd., Ergomed plc, Allergy Therapeutics, DMS Imaging, HAL Allergy B.V, ICB PHARMA, Bayer AG, Sanofi, Catalent, Inc., and GSK Plc.
In North America, the market is dominated by factors such as a higher prevalence of asthma and allergic rhinitis, increased indoor dust pollution, the presence of major industry players, and significant advancements in pharmaceutical research and development within the region.
Asia Pacific is poised to experience rapid growth in the house dust mite allergy treatment market, driven by a rising incidence of house dust mite allergies, greater awareness and education about allergens, increased healthcare spending, and the growing adoption of immunotherapy drugs for treating these allergies.
1.Executive Summary |
2.Global House Dust Mite Allergy Treatment Market Introduction |
2.1.Global House Dust Mite Allergy Treatment Market - Taxonomy |
2.2.Global House Dust Mite Allergy Treatment Market - Definitions |
2.2.1.Treatment |
2.2.2.Drug Type |
2.2.3.Route of Administration |
2.2.4.Region |
3.Global House Dust Mite Allergy Treatment Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global House Dust Mite Allergy Treatment Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global House Dust Mite Allergy Treatment Market By Treatment, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Antihistamine |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Immunotherapy |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global House Dust Mite Allergy Treatment Market By Drug Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Prescription Drugs |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Over-The-Counter Drugs |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global House Dust Mite Allergy Treatment Market By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Oral |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Nasal Drugs |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global House Dust Mite Allergy Treatment Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America House Dust Mite Allergy Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Treatment Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Antihistamine |
9.1.2.Immunotherapy |
9.1.3.Others |
9.2. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Prescription Drugs |
9.2.2.Over-The-Counter Drugs |
9.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Oral |
9.3.2.Nasal Drugs |
9.3.3.Others |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe House Dust Mite Allergy Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Treatment Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Antihistamine |
10.1.2.Immunotherapy |
10.1.3.Others |
10.2. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Prescription Drugs |
10.2.2.Over-The-Counter Drugs |
10.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Oral |
10.3.2.Nasal Drugs |
10.3.3.Others |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) House Dust Mite Allergy Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Treatment Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Antihistamine |
11.1.2.Immunotherapy |
11.1.3.Others |
11.2. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Prescription Drugs |
11.2.2.Over-The-Counter Drugs |
11.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Oral |
11.3.2.Nasal Drugs |
11.3.3.Others |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) House Dust Mite Allergy Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Treatment Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Antihistamine |
12.1.2.Immunotherapy |
12.1.3.Others |
12.2. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Prescription Drugs |
12.2.2.Over-The-Counter Drugs |
12.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Oral |
12.3.2.Nasal Drugs |
12.3.3.Others |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America House Dust Mite Allergy Treatment Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Treatment Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Antihistamine |
13.1.2.Immunotherapy |
13.1.3.Others |
13.2. Drug Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Prescription Drugs |
13.2.2.Over-The-Counter Drugs |
13.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Oral |
13.3.2.Nasal Drugs |
13.3.3.Others |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Shionogi & Co., Ltd. |
14.2.2.Stallergenes Greer |
14.2.3.Merck & Co., Inc. |
14.2.4.Torii Pharmaceutical Co., Ltd. |
14.2.5.Ergomed plc |
14.2.6.Allergy Therapeutics |
14.2.7.DMS Imaging |
14.2.8.HAL Allergy B.V |
14.2.9.ICB PHARMA |
14.2.10.Bayer AG |
14.2.11.Sanofi |
14.2.12.Catalent, Inc. |
14.2.13.GSK Plc. |
15. Research Methodology |
16. Appendix and Abbreviations |